AZD3264

A novel IkB-kinase IKK2 inhibitor for treatment of inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.

Target : I?B kinase (IKK)

CAS Number : 1609281-86-8

Formula Weight : 441.5034

Molecular Formula : C21H23N5O4S

Purity : >98% (HPLC)

Storage : (-20?)

Shipping Conditions : With Ice Pack

Stability : ? 2 years

Research use only, not for human use.